Search form

Latest News

Quidel Announces Timing of Filing of Form 8-K/A To Report Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses

SAN DIEGO--(BUSINESS WIRE)--Dec. 13, 2017--
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic
testing solutions, cellular-based virology assays and molecular
diagnostic systems, announced that it plans to file its required report
on Form 8-K/A with the Securities and Exchange Commission (the
“Commission”) after market close on . The Form
8-K/A will amend Quidel’s prior report on Form 8-K filed with the
Commission on that related to Quidel’s completed
acquisition of the Triage and BNP Businesses. The amendment is expected
to include the required audited abbreviated statements of assets
acquired and liabilities assumed and of revenues and direct expenses of
the Triage and BNP Businesses together with the required pro forma
information.

Read More »

Careers

Are you a determined, optimistic, team player? Quidel is looking for talented innovators who want to be part of revolutionizing medical diagnostics.

View Current Job Openings

Support

To place orders, get assistance with shipments, pricing or contract administration view our Customer Support page.

Visit our Technical Support page to get help with product specifications, supporting docs or general support issues.

NEW: Register at MyQuidel.com to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.